Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
09/2004
09/08/2004CN1526822A Method of raising antibacterial and antiviral property of plant
09/08/2004CN1526821A New glucoamylase and coding its nucleic acid sequence
09/08/2004CN1526820A Promotor for expressing gene in fungal cell
09/08/2004CN1526819A Method of transforming animal calcineurin gene into rice to raise its cold tolerance and salt tolerance
09/08/2004CN1526818A Method of blocking expression of hepatitis B virus
09/08/2004CN1526817A Anhydrant gene BcDh1 and the application of its promoter in raising drought-enduring plant
09/08/2004CN1526816A Specific inhibiting target site of blue-green alga TIM and its application
09/08/2004CN1526815A Common phytase
09/08/2004CN1526732A Process for producing high pureness albumin solution
09/08/2004CN1526728A Human tumor generating and metastasis promoting acceptor molecule and its encoding gene and application
09/08/2004CN1526727A Mouse tumor generating andmetastasis promoting acceptor and its encoding gene and application
09/08/2004CN1526726A Multisite mutant of human histiotype plasminogen activator
09/08/2004CN1526720A Process for recovering nucleic acid
09/08/2004CN1526446A Recombinant phage vaccine of tumor proliferation related growth factor and its application
09/08/2004CN1165764C Anti PSMA antibody or antigen binding part, and their use
09/08/2004CN1165763C Method for determining birds sex with egges and method of storing birds ovums
09/08/2004CN1165630C Method for determining nucleic acid sequence
09/08/2004CN1165629C Electropolymerizable film, and method of making and use thereof
09/08/2004CN1165622C Zero-background high-flux directed cloning expression method
09/08/2004CN1165621C Farnesyl diphosphate synthase
09/08/2004CN1165620C Mutant prenyl diphosphate synthase
09/08/2004CN1165619C Process for producing L-lysine
09/08/2004CN1165618C Polynucleotide immunogenic agents
09/08/2004CN1165617C Oligonucleotides for inhibiting expression of human eg5
09/08/2004CN1165615C Subtilase variants and compositions
09/08/2004CN1165614C Animal feed additives comprising xylanase
09/08/2004CN1165613C Protein for inhancing tolerance of colibacillus to L-amino acid, coding gene and use thereof
09/08/2004CN1165344C Compsns. and methods for catalyzing hydrolysis of HIV gp120
09/08/2004CN1165340C Cartilage/bone inducing materials for reparation
09/07/2004US6787687 Rin gene compositions and methods for use thereof
09/07/2004US6787684 Nucleotide sequences coding polypeptide for use in the generation of disease resistant plants
09/07/2004US6787683 Phytyl/prenyltransferase nucleic acids, polypeptides and uses thereof
09/07/2004US6787647 Carnitine carrier related protein-1
09/07/2004US6787646 Tumor suppressor molecules and methods of use
09/07/2004US6787645 Platelet derived growth factors; for stimulating and/or enhancing immune responsiveness and in wound healing and related tissue repair; for tumor suppression, cancer treatment
09/07/2004US6787644 Metalloprotease-disintegrin ADAM23 (SVPH3-17) nucleic acids
09/07/2004US6787643 Nucleic acid for use in kits for detection of preferential bacterial infection
09/07/2004US6787641 Identification of sel-12 and uses thereof
09/07/2004US6787639 Collectin
09/07/2004US6787634 Recognizes the extracellular domain of the human ifn-r and which has neutralizing capacity against the biological properties of human type i-ifn.
09/07/2004US6787519 Methods of treating disorders related to apoE
09/07/2004US6787364 Comprises a waveguide plate that reflects and wave-guides incident light; includes a surface with fixed sampling probes coupled to fluorescently labelled samples
09/07/2004US6787359 Gene transfer methods
09/07/2004US6787355 Multipotent neural stem cells from peripheral tissues and uses thereof
09/07/2004US6787352 Nucleotide sequences coding polypeptide fpr use in the human therapeutics, pharmacology, foods and animal feeds
09/07/2004US6787351 Composition for the prevention of preferential viral infections
09/07/2004US6787346 Kinase capable of site-specific phosphorylation of IκBα
09/07/2004US6787337 In vitro diagnosis of the formation of toxic or mutagenic metabolites (pollutants, drugs, pesticides); cytochromes
09/07/2004US6787336 DNA encoding growth hormone antagonists
09/07/2004US6787335 Polynucleotides and polypeptides which are diagnostic markers for mammary gland cancer.
09/07/2004US6787333 Retrovirus isolated from humans
09/07/2004US6787323 Monitoring vascular endothelial growth factor activity in a sample; obtain sample, incubate with preferential genetically engineered cells, detecting expression of the reporter element, expression indicates growth factor activity
09/07/2004US6787321 Mammalian two-hybrid system for screening for modulators of the accumulation of metabolic products
09/07/2004US6787319 Nucleotide sequences coding polypeptide for use in the treatment of alzheimer's disease
09/07/2004US6787316 DNA cloning method
09/07/2004US6787313 Dry deposit nondestructive particles on preferential surface; for use in the generation biochip microarrays
09/07/2004US6787310 Strand displacement methods employing competitor oligonucleotides for isolating one strand of a double-stranded nucleic acid
09/07/2004US6787309 Nucleotide sequences coding cardiovascular protein for use in the diagnosis and treatment chromosomal disorder
09/07/2004US6787307 Lysate clearance and nucleic acid isolation using silanized silica matrices
09/07/2004US6787305 Compositions and methods for enhanced synthesis of nucleic acid molecules
09/07/2004US6787145 Recombinant proteins of a pakistani strain of hepatitis E and their use in diagnostic methods and vaccines
09/07/2004US6787141 Peptide having for fibrinogen fragment E activity, analogs, antibodies and uses thereof
09/07/2004CA2248651C Method of identifying mhc-class i restriced antigens endogenously processed by a cellular secretory pathway
09/07/2004CA2173594C Methods and compositions of a bioartificial kidney suitable for use in vivo or ex vivo
09/07/2004CA2087006C Nucleic sequences from the genome of salmonella typhi, and uses thereof particularly for the in vitro diagnosis of the presence of salmonella bacteria in foodstuffs
09/06/2004CA2457423A1 Method for fermentative preparation of s-adenosylmethionine
09/02/2004WO2004074841A2 Kor3l-like-proteins and methods of modulating kor3l-mediated activity
09/02/2004WO2004074516A2 Method for enhancing efficacy of preparation of monoclonal antibody
09/02/2004WO2004074515A1 METHOD OF EVALUATING BEEF TASTE, TEXTURE AND SO ON BASED ON STEAROYL-CoA DESATURASE GENOTYPE
09/02/2004WO2004074514A2 Method of diagnosis of type 2 diabetes and early onset thereof
09/02/2004WO2004074511A1 Diagnosis and treatment of baff-mediated autoimmune diseases and cancer
09/02/2004WO2004074509A2 Reversible attachment of a membrane active polymer to a polynucleotide
09/02/2004WO2004074507A2 Method to confer cell culture replication activity to different hepatitis c virus isolates
09/02/2004WO2004074501A2 A method for obtaining structural information about an encoded molecule
09/02/2004WO2004074499A2 Combinatorial dna library for producing modified n-glycans in lower eukaryotes
09/02/2004WO2004074498A2 Expression of class 2 mannosidase and class iii mannosidase in lower eukaryotic cells
09/02/2004WO2004074497A2 Endomannosidases in the modification of glycoproteins in eukaryotes
09/02/2004WO2004074493A1 Recombinant mva and method for generation thereof
09/02/2004WO2004074492A1 Glyphosate tolerant sugar beet
09/02/2004WO2004074491A2 Expression in plants of antibodies against enterotoxigenic escherichia coli
09/02/2004WO2004074490A2 Method for transforming blakeslea strains
09/02/2004WO2004074488A1 Use of caspase enzymes for maturation of engineered recombinant polypeptide fusions
09/02/2004WO2004074487A1 Microbial production of coq10
09/02/2004WO2004074486A2 Fusion proteins of interferon alpha muteins with improved properties
09/02/2004WO2004074485A1 Novel proteins and dnas encoding the same
09/02/2004WO2004074484A1 Method of screening apoptosis-controlling agent
09/02/2004WO2004074483A1 Tsg gene-knockout animal
09/02/2004WO2004074482A1 Diabetes and obesity diagnosis method
09/02/2004WO2004074481A1 Glycorpotein antigen sima135 expressed in metastatic human tumor cells
09/02/2004WO2004074479A1 Methods of constructing biodiverse gene fragment libraries and biological modulators isolated therefrom
09/02/2004WO2004074474A1 Novel rna polymerase iii promoter, process for producing the same and method of using the same
09/02/2004WO2004074473A1 Mutant receptor and process for producing the same, method of separately evalauting ligands with the use of mutant receptor and normal receptor, screening method and kit therefor.
09/02/2004WO2004074469A1 Polypeptides comprising sequences characteristic of pyrrolidone carboxylic peptidases, polynucleotides comprising a sequence coding for said polypeptides, and use thereof particularly for diagnostic purposes
09/02/2004WO2004074466A1 Novel cell line, preparation method thereof and use of same, particularly for monitoring changes in chromatin texture
09/02/2004WO2004074462A2 Delta-endotoxin genes and methods for their use
09/02/2004WO2004074461A2 Production of modified glycoproteins having multiple antennary structures
09/02/2004WO2004074458A2 N-acetylglucosaminyltransferase iii expression in lower eukaryotes
09/02/2004WO2004074445A2 Model for studying the role of genes in tumor resistance to chemotherapy
09/02/2004WO2004074443A2 Glyphosate resistant class i 5-enolpyruvylshikimate-3-phosphate synthase (epsps)
09/02/2004WO2004074442A2 Plant regulatory sequences for selective control of gene expression